In 2017, Koerner et al. (2017) developed a series of ACLY inhibitors with chemical structures similar to that of anthraquinone emodin, which can induce apoptosis of non-small cell lung cancer cells by knocking down ACLY, thus achieving anti proliferation effect. This evidence concerns the gene ACLY and non-small cell lung carcinoma.